Synthekine

Synthekine is a privately held company based in Menlo Park, California, with a team of 104 employees. Synthekine specializes in the development of engineered cytokine therapeutics, focusing on treatments for cancer and autoimmune disorders. Their approach leverages immunological insights to guide targeted protein engineering, aiming to create transformative medicines. Synthekine's therapies are designed to be both safe and effective through the principles of cytokine partial agonism and immunological specificity. The company's lead programs have demonstrated promising efficacy and tolerability in preclinical studies. Synthekine is actively developing additional cytokine partial agonists that selectively modulate key pathways within the immune system. For more information about Synthekine and its innovative therapies, please visit their website at synthekine.com.